Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/14/2003CN1416855A Medicine for treating leukemia
05/14/2003CN1416853A Malignant tumor treating medicine and its prepn
05/14/2003CN1416851A Plaster for treating cancerous pain
05/14/2003CN1416850A Compound fig prepn for preventing and treating cancer and its prepn process
05/14/2003CN1416845A Medicated wine for treating duodenal cancer
05/14/2003CN1416826A Cancer-treating medicine and its prepn
05/14/2003CN1416816A Antineoplastic effect and medicine prepn of dioscin
05/14/2003CN1416814A Medicine prepn for injection and its prepn process
05/14/2003CN1416812A Liver-targeting mitomycin magnetic nano particle and its prepn and application in medicine
05/14/2003CN1416810A Taxol microemulsion as one new anticarcinogen prepn
05/14/2003CN1108294C Piperazine-2,5-dione derivatives as modulators of multidrug resistance
05/14/2003CN1108165C Traditional Chinese medicinal preparation for treating cancer
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/13/2003WO2002040048A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562995 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having
05/13/2003US6562962 Preparation of substituted isoserine esters using metal alkoxides and β-lactams
05/13/2003US6562960 Oligonucleotide analogues
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562863 Partially purified cocoa extracts containing cocoa polyphenols
05/13/2003US6562857 Cyanopyrroles
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562834 Combination comprising camptothecin and a stilbene derivative for the treatment of cancer
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562823 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562788 Novel class of peptide inhibitors of topoisomerase II chemotherapeutic antitumor agents
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562564 Decreasing cell proliferation by decreasing levels of PP5
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/13/2003US6562319 4-(phenylamino)quinazolines
05/13/2003US6562317 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content
05/13/2003US6562316 Drug delivery system with two-step targeting
05/13/2003CA2428649A1 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003CA2307048C Galenic preparation for prevention and treatment of hepatocarcinoma
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/08/2003WO2003038129A2 Methods for assessing and treating leukemia
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037912A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037897A2 Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037886A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037861A1 Use of 2-acylindoles in the treatment of tumors
05/08/2003WO2003037860A2 Purine analogs having hsp90-inhibiting activity
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037383A1 An antineoplastic- dendritic polymer drug delivery system
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037373A1 Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037347A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
05/08/2003WO2003037344A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
05/08/2003WO2003037340A1 Inhibitors of abc drug transporters in cancer cells
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037321A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
05/08/2003WO2003037318A1 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
05/08/2003WO2003037314A2 Medical compositions for intravesical treatment of bladder cancer
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037269A2 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
1 ... 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 ... 2211